INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Health and Society |
Texto Completo: | https://www.periodicojs.com.br/index.php/hs/article/view/1443 |
Resumo: | Introduction: Sars-CoV-2 imposed complex challenges on the global community, on March 11, 2020, when the World Health Organization (WHO) declared COVID-19 as a pandemic, it aroused concern from public and private health institutions internationally, due to to the high proportions of dissemination and risk to global health. Objective: to investigate the incidence of pulmonary thromboembolism (PT) in patients hospitalized for COVID-19 in an Intensive Care Unit (ICU) in southern Brazil. Method: documentary and descriptive research, quantitative approach, through a retrospective analysis of the medical records of patients treated at the ICU. Results: data collection resulted in 306 medical records of patients admitted to the ICU, 64.7% were positive for COVID-19, comprising the sample of interest for the present study, 59% men and 41% women, mean age 53, 8 ± 13.3 years, the constantly cited comorbidities were hypertension, diabetes mellitus and obesity. The sample showed an incidence of PT of 11% in the ICU, the PT+ group had a longer hospital stay compared to the COVID-19 group, angiotomography was performed 7.3 ± 6.3 days after the presence of symptoms compatible with PT, the morbidity and mortality was similar between groups. In the PT+ group, the length of stay and the presence of hypertension were greater than in the COVID-19 group. Conclusion: the understanding that COVID-19 is a respiratory disease, but that through its aggravation, it can evolve into a complication in the coagulative system, predisposing to thrombotic events, is essential, especially to recognize PT early, thus allowing greater chance in the treatment and early diagnosis of this disease. |
id |
IEPP-2_6a59bbf9ce3819e4a368f5e78519feb1 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/1443 |
network_acronym_str |
IEPP-2 |
network_name_str |
Health and Society |
repository_id_str |
|
spelling |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTEREmbolism Pulmonary. Respiratory Distress Syndrome. COVID-19Introduction: Sars-CoV-2 imposed complex challenges on the global community, on March 11, 2020, when the World Health Organization (WHO) declared COVID-19 as a pandemic, it aroused concern from public and private health institutions internationally, due to to the high proportions of dissemination and risk to global health. Objective: to investigate the incidence of pulmonary thromboembolism (PT) in patients hospitalized for COVID-19 in an Intensive Care Unit (ICU) in southern Brazil. Method: documentary and descriptive research, quantitative approach, through a retrospective analysis of the medical records of patients treated at the ICU. Results: data collection resulted in 306 medical records of patients admitted to the ICU, 64.7% were positive for COVID-19, comprising the sample of interest for the present study, 59% men and 41% women, mean age 53, 8 ± 13.3 years, the constantly cited comorbidities were hypertension, diabetes mellitus and obesity. The sample showed an incidence of PT of 11% in the ICU, the PT+ group had a longer hospital stay compared to the COVID-19 group, angiotomography was performed 7.3 ± 6.3 days after the presence of symptoms compatible with PT, the morbidity and mortality was similar between groups. In the PT+ group, the length of stay and the presence of hypertension were greater than in the COVID-19 group. Conclusion: the understanding that COVID-19 is a respiratory disease, but that through its aggravation, it can evolve into a complication in the coagulative system, predisposing to thrombotic events, is essential, especially to recognize PT early, thus allowing greater chance in the treatment and early diagnosis of this disease.Editora Acadêmica Periodicojs2023-07-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.periodicojs.com.br/index.php/hs/article/view/144310.51249/hs.v3i04.1443Health and Society; Vol. 3 No. 04 (2023); 78 - 94Health and Society; v. 3 n. 04 (2023); 78 - 942763-572410.51249/hs.v3i04reponame:Health and Societyinstname:Instituto de Ensino e Pesquisa Periodicojsinstacron:IEPPporhttps://www.periodicojs.com.br/index.php/hs/article/view/1443/1267Copyright (c) 2023 Sheila Adamczyk, Silvia Jaqueline Pereira de Souza, Junio César da Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAdamczyk, SheilaCésar da Silva, Junio Jaqueline Pereira de Souza, Silvia 2023-07-18T00:11:22Zoai:ojs.pkp.sfu.ca:article/1443Revistahttps://www.periodicojs.com.br/index.php/hs/PRIhttps://www.periodicojs.com.br/index.php/hs/oaijournalofhealthandsociety@gmail.com || periodicojs@gmail.com2763-57242763-5724opendoar:2023-07-18T00:11:22Health and Society - Instituto de Ensino e Pesquisa Periodicojsfalse |
dc.title.none.fl_str_mv |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER |
title |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER |
spellingShingle |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER Adamczyk, Sheila Embolism Pulmonary. Respiratory Distress Syndrome. COVID-19 |
title_short |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER |
title_full |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER |
title_fullStr |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER |
title_full_unstemmed |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER |
title_sort |
INCIDENCE OF PULMONARY THROMBOEMBOLISM IN PATIENTS WITH COVID-19 ADMITTED TO THE INTENSIVE CARE CENTER |
author |
Adamczyk, Sheila |
author_facet |
Adamczyk, Sheila César da Silva, Junio Jaqueline Pereira de Souza, Silvia |
author_role |
author |
author2 |
César da Silva, Junio Jaqueline Pereira de Souza, Silvia |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Adamczyk, Sheila César da Silva, Junio Jaqueline Pereira de Souza, Silvia |
dc.subject.por.fl_str_mv |
Embolism Pulmonary. Respiratory Distress Syndrome. COVID-19 |
topic |
Embolism Pulmonary. Respiratory Distress Syndrome. COVID-19 |
description |
Introduction: Sars-CoV-2 imposed complex challenges on the global community, on March 11, 2020, when the World Health Organization (WHO) declared COVID-19 as a pandemic, it aroused concern from public and private health institutions internationally, due to to the high proportions of dissemination and risk to global health. Objective: to investigate the incidence of pulmonary thromboembolism (PT) in patients hospitalized for COVID-19 in an Intensive Care Unit (ICU) in southern Brazil. Method: documentary and descriptive research, quantitative approach, through a retrospective analysis of the medical records of patients treated at the ICU. Results: data collection resulted in 306 medical records of patients admitted to the ICU, 64.7% were positive for COVID-19, comprising the sample of interest for the present study, 59% men and 41% women, mean age 53, 8 ± 13.3 years, the constantly cited comorbidities were hypertension, diabetes mellitus and obesity. The sample showed an incidence of PT of 11% in the ICU, the PT+ group had a longer hospital stay compared to the COVID-19 group, angiotomography was performed 7.3 ± 6.3 days after the presence of symptoms compatible with PT, the morbidity and mortality was similar between groups. In the PT+ group, the length of stay and the presence of hypertension were greater than in the COVID-19 group. Conclusion: the understanding that COVID-19 is a respiratory disease, but that through its aggravation, it can evolve into a complication in the coagulative system, predisposing to thrombotic events, is essential, especially to recognize PT early, thus allowing greater chance in the treatment and early diagnosis of this disease. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-07-17 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.periodicojs.com.br/index.php/hs/article/view/1443 10.51249/hs.v3i04.1443 |
url |
https://www.periodicojs.com.br/index.php/hs/article/view/1443 |
identifier_str_mv |
10.51249/hs.v3i04.1443 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.periodicojs.com.br/index.php/hs/article/view/1443/1267 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Sheila Adamczyk, Silvia Jaqueline Pereira de Souza, Junio César da Silva https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Sheila Adamczyk, Silvia Jaqueline Pereira de Souza, Junio César da Silva https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Editora Acadêmica Periodicojs |
publisher.none.fl_str_mv |
Editora Acadêmica Periodicojs |
dc.source.none.fl_str_mv |
Health and Society; Vol. 3 No. 04 (2023); 78 - 94 Health and Society; v. 3 n. 04 (2023); 78 - 94 2763-5724 10.51249/hs.v3i04 reponame:Health and Society instname:Instituto de Ensino e Pesquisa Periodicojs instacron:IEPP |
instname_str |
Instituto de Ensino e Pesquisa Periodicojs |
instacron_str |
IEPP |
institution |
IEPP |
reponame_str |
Health and Society |
collection |
Health and Society |
repository.name.fl_str_mv |
Health and Society - Instituto de Ensino e Pesquisa Periodicojs |
repository.mail.fl_str_mv |
journalofhealthandsociety@gmail.com || periodicojs@gmail.com |
_version_ |
1797047895015292928 |